Atlas Trials

The Effects of Vemurafenib + Cobimetinib on Immunity in Patients With Melanoma

Clinical trial NCT01813214 · TERMINATED

Trial details

NCT number
NCT01813214
Sponsor
Georgetown University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Melanoma
Start date
2013-03-01
Primary completion
2016-08-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.